ITGB3 and neoplasm: This stabilization sustains active integrin signaling pathways that drive oncogenic processes including proliferation, migration, and invasion - a finding consistent with previous reports of ITGB3 stabilization promoting tumor aggressiveness and therapy resistance across multiple cancer types [37].